DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebif (Interferon Beta-1a) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

REBIF SUMMARY

Rebif® (interferon beta-1a) is a purified 166 amino acid glycoprotein with a molecular weight of approximately 22,500 daltons.

Rebif® (interferon-beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. Efficacy of Rebif® in chronic progressive multiple sclerosis has not been established.


See all Rebif indications & dosage >>

REBIF NEWS HIGHLIGHTS

Published Studies Related to Rebif (Interferon Beta-1A)

Interferon Beta 1a versus Interferon Beta 1a plus Ribavirin for the Treatment of Chronic Hepatitis C in Chinese Patients: A Randomized, Placebo-Controlled Trial. [2008.08]

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-1a in moderately active ulcerative colitis. [2008.06.21]

Interferon Beta 1a versus Interferon Beta 1a plus Ribavirin for the Treatment of Chronic Hepatitis C in Chinese Patients: A Randomized, Placebo-Controlled Trial. [2007.12.13]

Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response. [2007.04]

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS. [2006.09.26]

more >>

Clinical Trials Related to Rebif (Interferon Beta-1A)

Rebif New Formulation (RNF) Quality of Life Study [Active, not recruiting]

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis [Completed]

Transition to Rebif New Formulation [Active, not recruiting]

Avonex (Interferon-Beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-Remitting MS [Active, not recruiting]

Phase II Cladribine Add-on to Inteferon-Beta (IFN-b) Therapy in MS Subjects With Active Disease [Recruiting]

more >>

REBIF PATIENT REVIEWS / RATINGS / COMMENTS

Based on a total of 1 ratings/reviews, Rebif has an overall score of 6. The effectiveness score is 8 and the side effect score is 6. The scores are on ten point scale: 10 - best, 1 - worst.
 

Rebif review by 29 year old female patient

  Rating
Overall rating:  
Effectiveness:   Considerably Effective
Side effects:   Moderate Side Effects
  
Treatment Info
Condition / reason:   Multiple Sclerosis
Dosage & duration:   250 mg taken 3x weekly for the period of 18 months
Other conditions:   none
Other drugs taken:   none
  
Reported Results
Benefits:   Reduce number of MS relapses
Side effects:   Flu like symptoms- aches, fever
Comments:   subcutaneous injection 3x weekly

See all Rebif reviews / ratings >>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008